Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Open Angle Glaucoma or Ocular Hypertension”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07335211
What this trial is testing

Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma (POAG)Ocular Hypertension
Huons Co., Ltd. 206
Large-scale testing (Phase 3)Study completedNCT02623738
What this trial is testing

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Santen Pharmaceutical Co., Ltd. 253
Large-scale testing (Phase 3)Looking for participantsNCT07662759
What this trial is testing

[KJ-TFC-005] Phase 3 Study, Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma Open-Angle PrimaryOcular Hypertension
Kukje Pharma 188
Post-approval studies (Phase 4)Study completedNCT02796560
What this trial is testing

Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Primary Open AngleOcular Hypertension
Université de Sherbrooke 76
Testing effectiveness (Phase 2)Study completedNCT01917383
What this trial is testing

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma

Who this might be right for
Primary Open-Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Inotek Pharmaceuticals Corporation 101
Not applicableStudy completedNCT01628601
What this trial is testing

GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 392
Testing effectiveness (Phase 2)Study completedNCT04742283
What this trial is testing

Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Santen Inc. 323
Testing effectiveness (Phase 2)Study completedNCT02136940
What this trial is testing

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
GlaucomaOcular HypertensionEye Disease
Amakem, NV 103
Post-approval studies (Phase 4)Study completedNCT00300079
What this trial is testing

Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Alcon Research 30
Large-scale testing (Phase 3)Ended earlyNCT02801617
What this trial is testing

Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle GlaucomaOcular Hypertension
Laboratorios Sophia S.A de C.V. 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT06964191
What this trial is testing

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
PolyActiva Pty Ltd 75
Post-approval studies (Phase 4)Study completedNCT04465864
What this trial is testing

Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert

Who this might be right for
Glaucoma, Primary Open AngleCataract
Wolstan and Goldberg Eye Associates 40
Early research (Phase 1)Study completedNCT04284514
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
Aerpio Therapeutics 91
Testing effectiveness (Phase 2)Study completedNCT00650338
What this trial is testing

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Santen Inc. 165
Testing effectiveness (Phase 2)Study completedNCT02537015
What this trial is testing

An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 81
Large-scale testing (Phase 3)Study completedNCT02617459
What this trial is testing

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-angle GlaucomaOcular Hypertension
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 366
Early research (Phase 1)Study completedNCT01943721
What this trial is testing

The VISION5 Product in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
ForSight Vision5, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT03896633
What this trial is testing

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

Who this might be right for
GlaucomaOpen Angle or Ocular Hypertension
Bausch & Lomb Incorporated 637
Not applicableStudy completedNCT00676637
What this trial is testing

Glaucoma Adherence Study

Who this might be right for
Ocular HypertensionPrimary Open Angle Glaucoma
Alcon Research 55
Post-approval studies (Phase 4)Study completedNCT00759239
What this trial is testing

Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation